AIThe Motley Foolabout 23 hours ago
Parabilis Soared 58% in Record Biotech IPO
1 min read
Parabilis Medicines raised $670 million in the biggest biotech IPO on record, topping Moderna's $604 million. The stock soared 58% on its first day. The company targets previously undruggable proteins using its Helicon platform, led by former Johnson & Johnson R&D head Mathai Mammen.
Level
Hype check
Tap to vote and see what everyone thinks.
